Mercado global de dispositivos médicos implantáveis ​​ativos – Tendências do setor e previsão para 2029

Análise de mercado e insights: Mercado global de dispositivos médicos implantáveis ​​ativos

O mercado de dispositivos médicos implantáveis ​​deverá testemunhar um crescimento do mercado a uma taxa de 8,00% no período de previsão de 2022 a 2029. O relatório Data Bridge Market Research sobre o mercado de dispositivos médicos implantáveis ​​proporciona análises e insights sobre os diversos fatores que deverão prevalecer em todo o período de previsão, ao mesmo tempo que fornece os seus impactos no crescimento do mercado. A ascensão do setor da saúde a nível global está a aumentar o crescimento do mercado de dispositivos médicos implantáveis.

Os dispositivos médicos implantáveis ​​ativos referem-se ao tipo de dispositivos destinados total ou parcialmente ao corpo de um paciente. Estes dispositivos destinam-se a fins de diagnóstico ou terapêutica no organismo humano. Os dispositivos entram no corpo humano através de um orifício natural ou por meios cirúrgicos.

O aumento da carga de doenças cardiovasculares em todo o mundo atua como um dos principais fatores que impulsionam o crescimento do mercado de dispositivos médicos implantáveis. Os investimentos e os fundos para desenvolver produtos tecnologicamente avançados e o cenário favorável de reembolso para os procedimentos otorrinolaringológicos nos países desenvolvidos aceleram o crescimento do mercado. O aumento da incidência de distúrbios neurológicos e a expansão das aplicações de neuroestimuladores influenciam ainda mais o mercado. Além disso, o aumento da prevalência da população geriátrica, o aumento dos gastos em saúde, os avanços nas infraestruturas de saúde e o elevado rendimento disponível afetam positivamente o mercado dos dispositivos médicos implantáveis. Além disso, o desenvolvimento de cardioversores desfibrilhadores implantáveis ​​subcutâneos (S-ICDs) estende oportunidades lucrativas aos participantes do mercado no período de previsão de 2022 a 2029.

Por outro lado, o elevado custo dos implantes e um cenário desfavorável de comparticipação e questões relacionadas com a utilização de dispositivos médicos implantáveis ​​obstruem o crescimento do mercado. O aumento da pressão sobre os preços e a escassez de profissionais qualificados deverão desafiar o mercado de dispositivos médicos implantáveis ​​no período de previsão de 2022-2029.

This implantable medical devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on implantable medical devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Active Implantable Medical Devices Market Scope and Market Size

The implantable medical devices market is segmented on the basis of product and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of product, the implantable medical devices market is segmented into implantable cardioverter defibrillators, ventricular assist devices, implantable cardiac pacemakers, dental implants, implantable hearing devices, ventricular assist devices and neurostimulators. Implantable cardioverter defibrillators is further sub-segmented into transvenous, and subcutaneous. Transvenous defibrillators are again sub-segmented into biventricular implantable cardioverter defibrillators (ICDs)/cardiac resynchronization therapy defibrillators (CRT-Ds), single-chamber implantable cardioverter defibrillators, and dual-chamber implantable cardioverter defibrillators. Implantable hearing devices are further sub-segmented into active hearing implants, and passive hearing implants. Neurostimulators are further sub-segmented into deep brain stimulators, spinal cord stimulators, sacral nerve stimulators, vagus nerve stimulators and gastric electrical stimulators.
• On the basis of end user, the implantable medical devices market is segmented into hospitals, ambulatory centers, cardiac centers, dental clinics and others.

Active Implantable Medical Devices Market Country Level Analysis

The implantable medical devices market is analyzed and market size insights and trends are provided by country, product and end user as referenced above.      

The countries covered in the implantable medical devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the implantable medical devices market because of the increase in prevalence of cardiovascular and neurological diseases within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the growth in geriatric population in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands impact of sales channels are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The implantable medical devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for implantable medical devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the implantable medical devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Active Implantable Medical Devices Market Share Analysis

The implantable medical devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to implantable medical devices market.

Alguns dos principais players que operam no relatório de mercado de dispositivos médicos implantáveis ​​são a Boston Scientific Corporation, Cochlear Ltd., Zimmer Biomet, Smith & Nephew, Johnson & Johnson Services, Inc., BIOTRONIK SE & Co. AG, Medtronic, Integra Lifesciences Holdings Corporation, Stryker, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG, CR Bard Inc., 3M, Dentsply Sirona, Allergan Inc., NuVasive, Inc., Cardinal Health, Inc., Microport Scientific Corporation, CONMED Corporation, Globus Medical, Inc. e MED-EL, entre outros.

SKU-10797